News
PRE
17.23
-1.82%
-0.32
Weekly Report: what happened at PRE last week (1102-1106)?
Weekly Report · 2d ago
Prenetics Announces 10-Year Global Care Bears Wellness Partnership
TipRanks · 5d ago
Prenetics Global Collaborates With Authentic Brands Group To Build Care Bears By IM8
Benzinga · 5d ago
Prenetics Names Brian J. Rosin Successor CFO
TipRanks · 11/03 14:49
Prenetics Global Appoints Brian J. Rosin CFO, Effective Dec. 31, Succeeding Stephen Lo
Benzinga · 11/03 14:08
Prenetics falls after CFO Stephen Hoi Chun tenders resignation
TipRanks · 11/02 18:48
Prenetics CFO Stephen Lo Resigns After Eight Years
TipRanks · 11/02 14:33
Weekly Report: what happened at PRE last week (1026-1030)?
Weekly Report · 11/02 10:09
Maxim Group Initiates Coverage of Prenetics Global at Buy
NASDAQ · 10/27 00:59
Press Release: First Horizon Declares Cash Dividends on Common and Preferred Stock
Dow Jones · 10/26 22:46
Prenetics Global Initiated at Buy by Maxim Group
Dow Jones · 10/26 16:38
Prenetics Global Price Target Announced at $41.00/Share by Maxim Group
Dow Jones · 10/26 16:38
Maxim Group Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $41
Benzinga · 10/26 16:28
Maxim starts Prenetics at Buy amid consumer interest in health and wellness
TipRanks · 10/26 13:05
Prenetics initiated with a Buy at Maxim
TipRanks · 10/26 12:10
Prenetics initiated with a Buy at Titan Partners
TipRanks · 10/26 10:56
Weekly Report: what happened at PRE last week (1019-1023)?
Weekly Report · 10/26 10:09
Weekly Report: what happened at PRE last week (1012-1016)?
Weekly Report · 10/19 10:09
Prenetics’ IM8 Strikes Multiyear Deal as NBA’s Official Nutrition Partner in Australia and Southeast Asia
TipRanks · 10/13 11:18
Lucid Capital Markets Initiates Coverage of Prenetics Global with Buy
NASDAQ · 10/12 17:01
More
Webull provides a variety of real-time PRE stock news. You can receive the latest news about Prenetics Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PRE
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.